News

A new radiotracer developed at the University of Alberta and soon to be tested in human clinical trials in Europe could make ...
Breast cancer is one of the most common cancers among women in the United States. Thanks to decades of fundamental research, ...
When she brought up cryoablation to her medical oncologist at the University of Alabama at Birmingham O’Neal Comprehensive ...
Access free, up-to-date clinical references about the risk factors of HER2-positive breast cancer. Healio's Clinical Guidance content provides valuable insights for physicians.
A new discovery by the Cold Spring Harbor Laboratory could help point toward the first effective therapy for triple-negative breast cancer. Triple-negative breast cancer accounts for 10 to 15% of all ...